A skincare startup got bought for $190 million—then shut down. Here's what entrepreneurs can learn from the rise and fall of ...

SHOPPING: Give yourself the gift of improved sense of self with the once-a-day treatment that contains ingredients to support ...

President Donald Trump has upended the global geopolitical order in place for more than 70 years with major economic ...

During the recent period between index selection dates, U.S. stock markets faced a steep decline, with the S&P 500 falling ...

Major cybersecurity breaches continue to plague the US healthcare industry, and on December 27, 2024, the U.S. Department of ...

Hims & Hers Health, Inc. stock faces volatility after an FDA halt on its GLP-1 drug. Click here to find out why HIMS stock is ...

Before healthcare organizations implement artificial intelligence tools, they need foundational technology and policies in place and a culture ready to embrace innovation.

Hims & Hers (HIMS) went all-in on weight-loss drugs. It bet big on cheaper, compounded versions of blockbuster GLP-1 treatments like ...